Third-party funding projects

| Read PDF file |

Please use landscape mode on your mobile phone

Projektleiter Projekttitel Finanzierungsquelle Laufzeit
Daniel Legler Common and ligand-biased CCR7 signaling dynamics in guiding leukocyte migration Schweiz. Nationalfonds SNF 310030_220205 2023-2027
Daniel Legler Masterstipendium und Gerätezuschuss Crescere Stiftung Thurgau 2022
Daniel Legler Doktorandenpatenschaften Schuler-Nufer Stiftung 2020-2024
Jérémie Rossy Understanding the dendritic cell side of the immunological synapse Schweiz. Nationalfonds Projekt No. 201059 2021-2025
Daniel Legler Doktorandenstipendium Crescere Stiftung Thurgau 2020
Daniel Legler Spitzenforschung am BITg TKB Jubiläums-Stiftung 2019-2022
Marcus Groettrup Immunotherapy of breast carcinoma through combination of PLGA-microsphere based vaccination with immune checkpoint blockade San Salvatore Foundation 2020-2021
Daniel Legler Understanding ligand-biased, spatio-temporal CCR7 signaling in guiding leukocyte migration Schweiz. Nationalfonds SNF 310030-189144 2019-2023
Jérémie Rossy Membrane scaffolding by Sorting Nexin 9 regulate CD28 signalling during T cell activation Novartis Foundation for Medical-Biological Research 2019
Daniel Legler Unravelling functional consequences of somatic human chemokine receptor CCR7 mutations in cancer Novartis Foundation for Medical-Biological Research (Project No. 19B094) 2019
Daniel Legler, Annette Aichem LI-COR Odyssey® Imaging System Lotteriefonds des Kantons Thurgau 2019
Daniel Legler Ko-Finanzierung eines TIRF-Mikroskops für die biomedizinische Forschung am BITg Thurgauische Krebsliga 2018
Jérémie Rossy Understanding the role of endosomes in T cells Schweiz. Nationalfonds 31003A_172969 2017-2020
Daniel Legler Elucidating distinct spatio-temporal CCR7 signaling complexes in controlling immune cell migration Schweiz. Nationalfonds SNF 31003A_169936 2016-2019
Michael Basler Identification of Immunoproteasome dependent factors involved in cytokine release and T cell differentiation SwissLife Jubiläumsstiftung 2016
Marcus Groettrup Investigating immunoproteasome inhibition as a new approach to colorectal cancer therapy Krebsliga Schweiz 2016-2019
Daniel Legler Ein purinerges Signalübertragungsrelais zur effizienten Zellmigration von Dendritischen Zellen und einer verbesserten Immunantwort gegen Infektionen und Krebs Vontobel Stiftung 2016-2018
Marcus Groettrup, Annette Aichem The role of FAT10 in the development of Leber congenital amaurosis (LCA) causing early childhood blindness: Characterizing the regulation and functional consequences of FAT10ylating phosphodiesterase 6 (PDE6) in the retina Velux Stiftung 2016-2019
Daniel Legler, Marcus Thelen, Cornelia Halin, Antal Rot Interplay of classical and atypical chemokine receptors in immune cell trafficking and dynamic microarchitecture of the secondary lymphoid organs Schweiz. Nationalfonds Sinergia (CRSII3_160719) 2015-2019
Michael Basler Identifikation der vom Immunproteasom abhängigen Faktoren, die eine Rolle in der Zytokinproduktion und T-Zelldifferenzierung spielen SwissLife Jubiläumsstiftung 2015
Hesso Farhan Systematic analysis of the regulation of the Golgi apparatus and its role in cell migration and polarity Schweiz. Nationalfonds SNF 31003A_156913 2014-2017
Daniel Legler Brustkrebsmetastasierung Thurgauische Krebsliga 2013-2015
Daniel Legler Functional consequences of a second, intracellular GPCR signaling complex Novartis Stiftung für Medizinisch-Biologische Forschung (Projekt Nr. 13B078) 2013-2015
Annette Aichem Post-translational modification of the transcription factor JunB by the ubiquitin-like modifier FAT10 and its impact on CD4+ Th1/Th2 helper cell differentiation during inflammatory infections Novartis Stiftung für Medizinisch-Biologische Forschung 2013-2014
Marcus Groettrup, Annette Aichem The ubiquitin-like modifier FAT10 and its role in the pathogenesis of Leber congenital amaurosis causing early childhood blindness Velux Stiftung 2013-2015
Daniel Legler Differential signaling through the chemokine receptor CCR7 by two ligands Schweiz. Nationalfonds SNF 31003A_143841 2012-2015
Daniel Legler High-throughput screening technology to identify biologics, ligands and ligand-induced interaction partners of G protein-coupled receptors KTI CTI 12516.1 PFLS-LS 2011-2012
Marcus Groettrup Immunoproteasome structure, assembly and function in the inflamed brain Schweiz. Nationalfonds SNF 31003A_138451 2011-2014
Hesso Farhan Phosphorylation of Sec16 and the regulation of endoplasmic reticulum exit sites (ERES) Schweiz. Nationalfonds SNF 31003A_135605 2011-2014
Daniel Legler, Hesso Farhan, Marcus Groettrup REquip: Laser scanning confocal microscope for imaging immunological and cell biological processes Schweiz. Nationalfonds SNF 316030_133812 2011-2012
Marcus Groettrup, Michael Basler Inhibitors of the immunoproteasome for the treatment of multiple sclerosis in pre-clinical models Schweiz. Multiple Sklerose Gesellschaft 2011-2012
Daniel Legler Regulation of metastasis formation and cell migration by MALT1 Pablo Frolich Stiftung 2010-2011
Daniel Legler Beitrag zur Anschaffung eines neuen Zellsorters Thurgauische Krebsliga 2010
Daniel Legler Modulation of dendritic cell functions and migration by prostaglandin E2 Schweiz. Nationalfonds SNF 31003A_127474 2009-2012
Daniel Legler Development of a high-throughput screening technology to identify ligands and ligand-induced interaction partners of G protein-coupled receptors KTI CTI 9807.1 PFLS-LS 2009-2011
Marcus Groettrup The failure of ER targeting as a source of antigen for presentation on MHC class I Schweiz. Nationalfonds SNF 3100_063387 2008-2011
Daniel Legler Zwei Sterilarbeitsplätze zur Aufarbeitung von Tumorgeweben und Zellen Thurgauische Krebsliga 2006
Daniel Legler Regulation of sprouty-2, spred and RGS9 by prostaglandin E2: role in dendritic cell migration Schweiz. Nationalfonds SNF 310030_112421 2006-2009
Daniel Legler Chemotaxis of human dendritic cells: regulation of chemokine receptor signal transduction through prostaglandin E2 Prof. Dr. Cloëtta Stiftung 2005-2010
Daniel Legler The role of prostaglandin E2 in dendritic cell-T cell interactions: towards the development of dendritic cell-based tumor vaccinations Vontobel Stiftung 2005-2008
Marcus Groettrup, Daniel Legler Regulation of CCR7 signal transduction through prostaglandin E2 and its role for dendritic cell migration and tumor vaccination Krebsliga Schweiz OCS-01309-02-2003 2003-2005